Literature DB >> 15254747

Diagnostic and classification value of metalloproteinases in squamous human laryngeal carcinoma.

T A Christopoulos1, N Papageorgakopoulou, D A Theocharis, A J Aletras, C P Tsiganos, T A Papadas, N S Mastronikolis, P Goumas, D H Vynios.   

Abstract

Metalloproteinases (MMPs) are a class of enzymes largely involved in tumour progression and metastasis. At least twenty different enzymes are recognized that are also present under normal state of tissues. Their activity is regulated by their presence as proenzymes and by the concomitant presence of the respective tissue inhibitors (TIMPs). The present study describes the alterations of MMPs observed in human laryngeal carcinoma with respect to tumour classification and compares their activity in normal and cancerous tissues and biopsy specimens. Samples from five patients who underwent laryngectomy, from five biopsies and three from autopsies were used. The MMPs of normal and malignant human laryngeal cartilage and of biopsy specimens were identified immunochemically and by zymography using gelatin or casein as substrates. Healthy cartilage from autopsies was found to contain almost exclusively MMP-1, proMMP-2 and proMMP-9. Normal parts from laryngectomies contained, in addition, significant amounts of active MMP-2. The respective malignant parts contained both MMP-2 and -9 in increased amounts in their latent and active forms. Similar profile of MMPs was also identified in tissues surrounding affected cartilage. These alterations were found to be in good accordance with tumour stage and were also observed in biopsy samples. Thus, analysis of MMPs in biopsies can be used together with the clinicopathological parameters for the classification or early diagnosis of laryngeal tumours.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254747

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

1.  Matrix metalloproteinase 2 (MMP2) protein expression and laryngeal cancer prognosis: a meta analysis.

Authors:  Rong-Rong Liu; Ming-Dong Li; Te Li; Yun Tan; Min Zhang; Ji-Chuan Chen
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Matrix metalloproteases in head and neck cancer.

Authors:  Eben L Rosenthal; Lynn M Matrisian
Journal:  Head Neck       Date:  2006-07       Impact factor: 3.147

3.  The chondroitin/dermatan sulfate synthesizing and modifying enzymes in laryngeal cancer: expressional and epigenetic studies.

Authors:  Dimitrios Kalathas; Irene-Eva Triantaphyllidou; Nicholas S Mastronikolis; Panos D Goumas; Thoedore A Papadas; Gabriel Tsiropoulos; Demitrios H Vynios
Journal:  Head Neck Oncol       Date:  2010-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.